Home
About
Overview
Sharing Data
ORCID
Help
History (5)
A tribute to the career of a gentle giant of peptide science.
Ancrod
Final analysis of a phase 1/2b study of ibrutinib combined with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma.
Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens.
Transportation and retention in outpatient drug abuse treatment programs.
See All 5 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Transportation and retention in outpatient drug abuse treatment programs.
Friedmann PD, Lemon SC, Stein MD. Transportation and retention in outpatient drug abuse treatment programs. J Subst Abuse Treat. 2001 Sep; 21(2):97-103.
View in:
PubMed
subject areas
Adult
Ambulatory Care
Female
Humans
Male
Patient Compliance
Patient Dropouts
Substance Abuse Treatment Centers
Substance-Related Disorders
Transportation of Patients
Treatment Outcome
authors with profiles
Peter D Friedmann MD, MPH, DFASAM, FACP
Stephenie C Lemon PhD